tiprankstipranks
Phio Pharmaceuticals (PHIO)
NASDAQ:PHIO
US Market
PHIO
Phio Pharmaceuticals
RESEARCH TOOLSreports
Want to see PHIO full AI Analyst Report?

Phio Pharmaceuticals (PHIO) Income Statement

651 Followers

Phio Pharmaceuticals Income Statement

Last quarter (Q4 2025), Phio Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Phio Pharmaceuticals's net income was $-2.37M. See Phio Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -3.00K$ -3.64M$ -6.33M$ -7.01M$ -8.89M
Operating Expenses
$ 9.22M$ 3.74M$ 4.49M$ 4.45M$ 4.63M
Depreciation and Amortization
$ 3.00K$ 2.00K$ 184.00K$ 71.00K$ 75.00K
EBITDA
$ -9.22M$ -7.38M$ -10.64M$ -11.39M$ -13.44M
Operating Income
$ -9.22M$ -7.39M$ -10.82M$ -11.46M$ -13.51M
Other Income/Expenses
$ 522.00K$ 237.00K$ -2.00K$ -18.00K$ 224.00K
Pretax Income
$ -8.70M$ -7.15M$ -10.83M$ -11.48M$ -13.29M
Net Income
$ -8.70M$ -7.15M$ -10.83M$ -11.48M$ -13.29M
Per Share Metrics
Basic EPS
$ -1.45$ -0.91$ -46.87$ -89.61$ -111.32
Diluted EPS
$ -1.45$ -0.91$ -46.76$ -89.61$ -111.32
Weighted Average Shares Outstanding
 5.98M 787.47K 231.00K 126.16K 118.68K
Weighted Average Shares Outstanding (Diluted)
 5.98M 787.47K 231.51K 126.16K 118.68K
Currency in USD

Phio Pharmaceuticals Earnings and Revenue History